About

cross-disciplinary glyco-scientists with approximately 100 years of combined experience in glycobiology, carbohydrate chemistry, enzyme technology, microbial fermentation, and metabolic engineering.

Mr. Jason Moore is an accomplished entrepreneur with a proven track record in finance and legal matters.
His proficiency spans product development, making him a valuable asset in driving GlycoSky's strategic initiatives and growth.

Dr. Gyula Dekany is a serial entrepreneur and glycotechnology expert with a rich history in the industry.
As the principle-founder and former CSO of Glycom A/S, principle-founder and former CEO of CarboCode GmbH, and co-founder of Alchemia, CarboCalyx, and CarboCode Pharma, Gyula brings a wealth of experience in both academic research and senior management roles in the business and glycotechnology development sectors.
His expertise and leadership are invaluable assets in driving innovation and strategic growth at GlycoSky.

Dr. Heykel Trabelsi is a biotech expert with over 15 years of experience in protein and microbial strain engineering, complemented by glycobiotechnology expertise.
As the former Head of Metabolic Engineering at CarboCode GmbH, Heykel developed new metabolic routes and innovative methodologies to generate complex protein and oligosaccharide-producing strains at an industrial level.
His extensive experience and technical wisdom make him a valuable asset in driving technological advancements and innovation at GlycoSky.

Dr. Alex Dennig is a distinguished industrial biotech expert renowned for his expertise in glycobiochemistry and enzyme technology, with over 15 years of experience in the field.
Our incoming CSO played a pivotal role in developing and scaling key technologies essential to the realm of human nutrition.
His contributions have been instrumental in driving innovation and success in the biotechnology sector and will do so at GlycoSky.

Piroska Kovacs Penzes is a skilled analytical scientist with extensive experience in glycoanalytics including monosaccharide, oligosaccharide and glycoconjugate analytics, product development, analytical networking, and regulatory support.
She had significant impact on the scientific success of both Glycom and CarboCode by leading all scale-up related analytics of HMOs at Glycom and masterminding the analytical landscape of glycolipids at CarboCode.
She has a proven track record in specification settings, impurity profile analysis, and method development, making her a valuable asset in ensuring analytical excellence and regulatory compliance at GlycoSky.

Dr. Yevhenii Sokolenko, the incoming Head of Chemistry at GlycoSky starting in 2025, is an innovative chemist with over 10 years of profound research experience in synthetic organic chemistry.
He currently serves as a Research Scientist at Danish Technical University, Copenhagen. He has been a main contributor to numerous scientific projects encompassing drug discovery, organic synthesis, and glycosphingolipid chemistry.
Yevhenii's expertise and creativity have been instrumental in advancing scientific endeavors, making him a young rising star in the field of chemistry. He previously worked as a scientist at Enamine Ltd. and CarboCode Germany GmbH, further solidifying his background in both academia and industry.